Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
A phase I dose-escalation/expansion study of fractionated-dose and multiple cycle anti-PSMA-targeted alpha emitter 225Ac-J591 in patients with prostate cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 17, 2026
Baseline Imaging Derived Factors of Response Following [225Ac]Ac-J591 Therapy in Metastatic Castration-Resistant Prostate Cancer: A Lesion Level Analysis.
Journal: The Prostate
Published: August 26, 2024
Prostate-Specific Membrane Antigen: Gateway to Management of Advanced Prostate Cancer.
Journal: Annual review of medicine
Published: January 29, 2024
Prostate-Specific Membrane Antigen-Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 03, 2023
α-Labeling of J591, an Antibody Targeting Prostate-Specific Membrane Antigen: The Technique and Considerations from the First Dedicated Production Lab at an Academic Institution in the United States.
Journal: Journal of nuclear medicine technology
Published: November 11, 2022
Correction to: [89Zr]Zr‑huJ591 immuno‑PET targeting PSMA in IDH mutant anaplastic oligodendroglioma.
Correction to: [89Zr]Zr‑huJ591 immuno‑PET targeting PSMA in IDH mutant anaplastic oligodendroglioma.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 10, 2022
Folate hydrolase-1 (FOLH1) is a novel target for antibody-based brachytherapy in Merkel cell carcinoma.
Journal: Skin health and disease
Published: September 20, 2021
Prostate-Specific Membrane Antigen Positron Emission Tomography and the New Algorithm for Patients With Prostate Cancer Prior to Prostatectomy.
Journal: JAMA oncology
Published: September 16, 2021
Pilot study of the diagnostic utility of 89 Zr-df-IAB2M and 68 Ga-PSMA-11 PET imaging and multiparametric MRI in localized prostate cancer.
Journal: The Prostate
Published: September 07, 2021
Last Updated: 09/26/2026